Skip to main content
letter
. 2018 Sep 5;131(17):2122–2124. doi: 10.4103/0366-6999.239313

Supplementary Table 2.

Comparison of clinicopathological characteristics of patients treated with curative intent classified according to the extent of lymphadenectomy

Clinicopathological characteristics D1/D1+ (n = 68) D2 (n = 132) P
Gender (male), n (%) 56 (82.4) 103 (78.0) 0.473
Age (years), mean ± SD 78.8 ± 3.2 77.9 ± 3.2 0.061
Charlson comorbidity score, n (%)
 <2 37 (54.4) 92 (69.7) 0.032
 ≥2 31 (45.6) 40 (30.3)
BMI (kg/m2), mean ± SD 22.0 ± 3.7 22.0 ± 3.8 0.926
Performance status, n (%)
 0 3 (4.4) 3 (2.3) 0.142
 1 17 (25.0) 54 (40.9)
 2 37 (54.4) 59 (44.7)
 3 11 (16.2) 16 (12.1)
POSSUM, n (%)
 <20 35 (51.5) 91 (68.9) 0.015
 ≥20 33 (48.5) 41 (31.1)
Type of gastrectomy, n (%)
 Subtotal 55 (80.9) 93 (70.5) 0.111
 Total 13 (19.1) 39 (29.5)
Tumor location, n (%)
 Upper one-third 31 (45.6) 28 (21.2) 0.001
 Middle one-third 3 (4.4) 18 (13.6)
 Lower one-third 28 (41.2) 59 (44.7)
 Two-thirds or more 6 (8.8) 27 (20.5)
Tumor size (cm), mean ± SD 4.3 ± 2.0 4.7 ± 1.7 0.145
Histology, n (%)
 Differentiated 29 (42.6) 59 (44.7) 0.782
 Undifferentiated 39 (57.4) 73 (55.3)
Histotype (Lauren), n (%)
 Intestinal 36 (52.9) 64 (48.5) 0.748
 Diffuse 13 (19.1) 34 (25.8)
 Mixed 15 (22.1) 28 (21.2)
 Other 4 (5.9) 6 (4.5)
Grading (Bormann), n (%)
 I 8 (11.8) 26 (19.7) 0.496
 II 17 (25.0) 33 (25.0)
 III 42 (61.8) 72 (54.5)
 IV 1 (1.4) 1 (0.7)
pT, n (%)
 T1 7 (10.3) 15 (11.4) 0.081
 T2 5 (7.4) 14 (10.6)
 T3 8 (11.7) 33 (25.0)
 T4 48 (70.6) 70 (53.0)
pN, n (%)
 N0 21 (30.9) 40 (30.3) 0.933
 N+ 47 (69.1) 92 (69.7)
pTNM stage, n (%)
 I 10 (14.7) 19 (14.4) 0.784
 II 15 (22.1) 35 (26.5)
 III 43 (63.2) 78 (59.1)

BMI: Body mass index; D1/D1+: Patients who underwent R0 resection and D1 or D1+ lymphadenectomy; D2: Patients who underwent R0 resection and D2 lymphadenectomy; POSSUM: Physiological and operative severity score for the enumeration of mortality and morbidity; SD: Standard deviation.